BamSEC and AlphaSense Join Forces
Learn More

Oxford Immunotec Global PLC

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Third Amendment to Purchase Agreement
12/34/56
EX-10.35
from 10-K 10 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to the Amended and Restated Supply and Reseller Agreement
12/34/56
EX-10.3
from 10-Q 3 pages The Symbol “[***]” Denotes Places Where Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material, and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed Sixth Amendment to Distributorship Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because Such Information Both (I) Is Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Excluded Information Is Indicated With Brackets and Asterisks. Amendment of Agreement Between Quest Diagnostics Incorporated and Oxford Immunotec USA, Inc
12/34/56
EX-10.47
from 10-K 8 pages Separation Agreement
12/34/56
EX-10.13
from 10-K 35 pages This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. Amended and Restated Supply and Reseller Agreement
12/34/56
EX-10.12
from 10-K 21 pages This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. Supplier Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Date Name Address Re: Bonus Agreement Dear , 1. Amount and Payment of Special Bonus
12/34/56
EX-10.2
from 10-Q 3 pages Date Name Address Re: Bonus Agreement Dear , 1. Amount and Payment of Special Bonus
12/34/56
EX-10.1
from 10-Q 2 pages This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. Fifth Amendment to Distributorship Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Fourth Amendment to Distributorship Agreement
12/34/56
EX-10.50
from 10-K 10 pages Employment Agreement
12/34/56
EX-10.44
from 10-K 6 pages Form of Officer Stock Option Award Granted Under Appendix D to the Oxford Immunotec Global PLC 2013 Share Incentive Plan
12/34/56
EX-10.33
from 10-K 33 pages Oxford Immunotec Global PLC 2013 Amended Share Incentive Plan Approved by the Shareholders on June 6, 2017 Rules of the Oxford Immunotec Global PLC 2013 Share Incentive Plan
12/34/56
EX-10.21
from 10-K 2 pages Third Amendment to Distributorship Agreement
12/34/56
EX-10.5
from 10-K 17 pages Second Amendment to Purchase Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Second Amendment to Supply Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Marketing Authorization Holder Agreement
12/34/56